Hopfner Robert Lorne

Average Profitability
<0.0001%
Insider Buys Quantity
10
Insider Buys Sum
$26.68M
Insider Sells Quantity
21
Insider Sells Sum
$42.73M

Insider Activity of Hopfner Robert Lorne

The largest purchase of all time was on 2021-08-02 and amounted to 576923 shares of Rallybio Corporation for $7.5M.

The largest sale of all time was on 2021-02-09 and amounted to 441488 shares of Vaxcyte, Inc. for $12.45M.

Biography of Hopfner Robert Lorne

No biography is available at this moment.

2023-08-01PurchaseInozyme Pharma, Inc.
INZY
director
833,333
1.4418%
$4.80$4M-7.57%
2023-05-12PurchaseInozyme Pharma, Inc.
INZY
director
228,702
0.5377%
$6.25$1.43M-20.56%
2023-05-11PurchaseInozyme Pharma, Inc.
INZY
director
219,230
0.5045%
$6.48$1.42M-24.92%
2023-03-29PurchaseInozyme Pharma, Inc.
INZY
director
344,592
0.761%
$4.54$1.56M+7.66%
2023-03-28PurchaseInozyme Pharma, Inc.
INZY
director
156,766
0.3414%
$4.16$652,335+14.87%
2023-03-27PurchaseInozyme Pharma, Inc.
INZY
director
51,074
0.1167%
$3.70$188,729+35.68%
2022-04-19PurchaseInozyme Pharma, Inc.
INZY
1.07M
2.2197%
$3.69$3.95M-33.04%
2021-08-02PurchaseRallybio Corporation
RLYB
director
576,923
1.5136%
$13.00$7.5M-39.61%
2021-02-10SaleVaxcyte, Inc.
PCVX
director
156,316
0.3024%
$26.53$4.15M-14.96%
2021-02-09SaleVaxcyte, Inc.
PCVX
director
441,488
0.8718%
$28.19$12.45M-18.32%
2021-02-08SaleVaxcyte, Inc.
PCVX
director
159,592
0.3087%
$25.79$4.12M-12.2%
2021-02-03SaleVaxcyte, Inc.
PCVX
director
5,536
0.0112%
$25.06$138,732-4.97%
2021-02-02SaleVaxcyte, Inc.
PCVX
director
28,468
0.0559%
$25.13$715,401-8.16%
2021-01-28SaleVaxcyte, Inc.
PCVX
director
4,000
0.0081%
$25.07$100,280-4.68%
2021-01-27SaleVaxcyte, Inc.
PCVX
director
4,280
0.0086%
$25.30$108,284-6.27%
2021-01-26SaleVaxcyte, Inc.
PCVX
director
36,284
0.0726%
$25.30$917,917-6.59%
2021-01-25SaleVaxcyte, Inc.
PCVX
director
69,944
0.1353%
$25.81$1.81M-11.35%
2021-01-22SaleVaxcyte, Inc.
PCVX
director
22,766
0.0445%
$25.16$572,793-7.78%
2021-01-21SaleVaxcyte, Inc.
PCVX
director
200
0.0004%
$25.11$5,022-1.94%
2021-01-20SaleVaxcyte, Inc.
PCVX
director
38,092
0.0764%
$25.35$965,632-5.91%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.